Light Therapy for Peripheral Neuropathy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a light therapy treatment (Anodyne Therapy System) to assist childhood cancer survivors with Chemotherapy Induced Peripheral Neuropathy (CIPN), a condition causing numbness or pain in the hands and feet. The trial aims to determine if participants can easily use the light therapy at home for six weeks and if it reduces symptoms. Participants will undergo a baseline evaluation, complete 18 short therapy sessions over six weeks primarily at home, and then have a final check-up. This trial suits childhood cancer survivors with CIPN symptoms who received specific chemotherapy drugs. As an unphased trial, it offers a unique opportunity for participants to contribute to research that could enhance home-based treatments for CIPN.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this light therapy protocol is safe for childhood cancer survivors?
Research has shown that the Anodyne Therapy System, used in the light therapy trial, is generally safe. This system, a type of light therapy, has FDA approval for home or office use. Studies have found it can effectively increase blood flow in specific areas and aid in nerve pain and wound healing. Most people tolerate it well.
However, some considerations are necessary. The therapy is not recommended for pregnant women, individuals sensitive to light, or those with certain heart conditions. Major side effects have not been commonly reported, making it a promising option for many. Consulting a doctor is essential to determine if this treatment is suitable.12345Why are researchers excited about this trial?
Researchers are excited about light therapy for peripheral neuropathy because it offers a non-invasive approach that directly targets pain and nerve damage without the need for medications. Unlike traditional treatments like pain relievers or topical creams, light therapy uses specific wavelengths to potentially improve blood circulation and promote healing at the cellular level. This method could provide relief with minimal side effects and allow patients to perform most sessions conveniently at home, enhancing accessibility and ease of use.
What evidence suggests that the Anodyne Therapy System is effective for Chemotherapy Induced Peripheral Neuropathy?
Research on the Anodyne Therapy System, which participants in this trial will receive, has shown mixed results. Some studies suggest it may improve sensation and reduce pain in the lower body. However, other research found it no more effective than a placebo for enhancing nerve function in people with diabetes. Ongoing research into near-infrared light therapy has shown potential in reducing pain and burning sensations after a few sessions. Overall, while some findings are promising, the effectiveness of Anodyne therapy for conditions like peripheral neuropathy remains uncertain.678910
Who Is on the Research Team?
Rozalyn Rodwin, MD
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
This trial is for childhood cancer survivors who were diagnosed before turning 21, are now at least five years old, and have nerve damage from certain chemotherapy drugs. They must have a specific level of neuropathy as measured by a physical therapist.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Evaluation
Baseline evaluation in clinic to assess initial neuropathy symptoms and conduct the first light therapy session
Treatment
Participants complete 18 light therapy sessions over 6 weeks, with 3 sessions per week at home
Follow-up
Participants are monitored for changes in neuropathy symptoms and gait efficiency post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Anodyne Therapy System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
Rally Foundation for Childhood Cancer Research
Collaborator